Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Fosun"


25 mentions found


In the Arts, Is It Breaking Big, or Selling Out?
  + stars: | 2024-05-02 | by ( Farah Nayeri | ) www.nytimes.com   time to read: +1 min
The 11-foot sculpture looks like something out of a comic strip: a luxury handbag perched on skinny legs and matched with high-end sneakers. The work is by the Austrian-born artist Erwin Wurm, and it represents accessories from the collections of Lanvin, the French fashion house. “Desire” (the title of the sculpture) was commissioned by Lanvin and unveiled in Beijing in early April. “I made this piece because it fit into my series,” Wurm, 69, said in a phone interview, referring to his “walking bag” sculptures, which parody women’s contemporary passion for handbags. “I reduce females to long legs and shoes and handbags.
Persons: Erwin Wurm, , , Lanvin, ” Wurm Organizations: Shanghai —, Fosun Foundation, Fosun Locations: Austrian, Beijing, Shanghai
Japan's Asahi Group Holdings has plans to dive back into the China market as it looks to revive investments in the world's largest beer market. The company divested from China years ago due to the lack of "premiumized products" and "very low" prices at that time, Katsuki said. In 2017, Asahi announced it would sell its nearly 20% stake in China's Tsingtao Brewery to Fosun Group and its subsidiaries. "But with the entry of the international brands and also craft beer, the premium segment in China is now really taking off and growing substantially." "Asahi Super Dry has the largest sales already from the China market now and it's growing double digits every year, so we want to continue to really invest into this premium market," he added.
Persons: We've, Atsushi Katsuki, CNBC's Martin Soong, we're, Katsuki Organizations: Japan's Asahi Group Holdings, Asahi, Fosun Group Locations: China, Tsingtao
Blackstone acquires International Gemological Institute
  + stars: | 2023-05-21 | by ( ) www.reuters.com   time to read: +1 min
MUMBAI, May 21 (Reuters) - Private equity giant Blackstone Inc(BX.N) said it has fully acquired the jewellery certification firm International Gemological Institute (IGI) from China's Fosun(0656.HK) and the company's founding family. Blackstone acquired IGI- whose majority revenue and profits come from India- for about $530 million, said a person with direct knowledge of the matter. The statement said it had purchased an 80% stake from Fosun and 20% from the Lorie family. Founded nearly 50 years ago by the late Marcel Lorie, IGI has 29 laboratories and 18 schools of gemology in 10 countries. India's jewellery market was worth is $78.5 billion in the 2021 financial year and its one of the world's biggest, though a significant portion goes for export.
LONDON/LISBON, May 19 (Reuters) - Portuguese insurer Fidelidade is exploring a potential stock market listing of its private healthcare subsidiary Luz Saude, six people familiar with the matter told Reuters. Luz Saude reported operating income of 599 million euros in 2022, a 10.6% jump from the year before, driven by growth in private healthcare services. They come after Fidelidade acquired the remaining 49% of Luz Saude it did not already own from parent Fosun in September. An IPO would mark a return of Luz Saude to the stock market after the healthcare group stopped trading on Euronext Lisbon in 2018. It could also awaken Europe's IPO market, after activity levels plunged last year on the back of soaring interest rates and economic uncertainty.
REUTERS/Aly Song/File PhotoSYDNEY/HONG KONG, May 8 (Reuters) - Alibaba's (9988.HK) logistics arm aims to raise up to $2 billion via a listing in Hong Kong likely early next year, sources with knowledge of the matter said, bolstering hopes for a capital markets revival in the Asian financial hub. Cainiao, which has started work on the IPO, is looking to raise between $1 billion and $2 billion in Hong Kong, according to three sources. IPO PROSPECTSDealmakers hope that Cainiao's potential IPO, expected to be followed by market debuts from some of the other Alibaba units in the near-term, could help revive sluggish fundraising activities in Hong Kong. About $1.5 billion has been raised from IPOs in Hong Kong so far this year, marginally above the $1.2 billion raised in the same period last year, according to Refinitiv data. ($1 = 6.9149 Chinese yuan renminbi)Reporting by Scott Murdoch in Sydney and Julie Zhu in Hong Kong; Editing by Sumeet Chatterjee and Jamie FreedOur Standards: The Thomson Reuters Trust Principles.
MILAN, May 4 (Reuters) - Italy's top insurer Generali (GASI.MI) said on Thursday it had agreed to sell its German specialised pension unit to Fosun-backed Frankfurter Leben as it seeks to improve profitability in the life business and free up capital. By selling Generali Deutschland Pensionskasse (GDPK), the Italian insurer will add one percentage point to its Solvency position and around 10 percentage points to that of its German holding company, it said in a statement. In 2019 Generali sold a majority stake in life insurer Generali Leben, to private equity-backed Viridium, as it sought to cut risks on savings business amid record low interest rates. Generali said that the deal to sell GDPK was expected to be completed by the end of 2023, subject to the approval of the German financial regulator BaFin and some local anti-trust authorities. Frankfurter Leben Group is majority-owned by Fosun International (0656.HK) and specialises in buying life insurance portfolios from other insurers and continuing to manage them.
The company posted a 95% year-on-year dip in annual 2022 profits. "It's not pathetic that we are selling assets," he said at an entrepreneur forum in March, per Bloomberg. Hong Kong stock exchange-listed Fosun International's shares have rebounded to 5.4 Hong Kong dollars, or $0.7, apiece on Tuesday, from a low of 4.6 Hong Kong dollars in September. They're still down from about 7.8 Hong Kong dollars in late January. Fosun International's market capitalization is around 44 billion Hong Kong dollars now.
Last Friday, authorities opened a similar probe into Liu Liange, former chairman of state-owned Bank of China, the country’s fourth largest lender. And in January, Wang Bin, who headed state-owned China Life Insurance from 2018 to early 2022, was charged by national prosecutors with taking bribes and hiding overseas savings. They include financial giants such as China Investment Corp, the nation’s sovereign wealth fund, China Development Bank, which provides financing for key government projects, and Agricultural Bank of China, another large state-controlled lender. “The current financial crackdown is a new wave of Xi Jinping’s anti-corruption campaign against the financial sector for consolidation of his power,” said Chongyi Feng, an associate professor in China Studies at the University of Technology Sydney. But the deepening crackdown on the vast financial sector could rattle investors.
In this picture taken on October 12, 2016 a general view shows the Club Med resort in Sanya. Nicolas Asfouri | Afp | Getty ImagesClub Med is "very optimistic" about China's reopening, an executive from Fosun Tourism Group told CNBC Monday, adding that the luxury resort chain is "definitely not for sale." Bloomberg reported in November that Fosun International is exploring "strategic options" for Club Med as a means to reduce debt. "We are actually happy to see if … partners in different parts of the world can give synergy for us, but definitely Club Med is not for sale," said Xu, who is also the CEO of Club Med China. Hong Kong-listed shares of Fosun Tourism Group rose 0.93% while shares of Fosun International were 3% lower on Monday, marking the lowest levels it's seen since December.
BEIJING, Feb 26 (Reuters) - China Renaissance Holdings (1911.HK) said in an exchange filing on Sunday that its missing chairman and star dealmaker Bao Fan was currently cooperating with relevant Chinese authorities conducting an investigation. This is the first time the mainland China-based boutique bank has given a reason for the disappearance of its founder -- who was reported missing 10 days ago -- though no details about the investigation were shared. "The Board would like to reiterate that the business and operations of the Group are continuing normally," the bank said in the exchange filing. Reuters previously reported, citing sources, that authorities took Bao away earlier this month to assist in an investigation into a former colleague, Cong Lin, the company's former president. read moreBao's disappearance also comes against the backdrop of more than two years of sweeping regulatory crackdown on technology companies.
Following is a list of some other high-profile Chinese executives who have abruptly gone missing from public view in recent years. Three months later, On Nov. 27, the company said Yang had resumed his duties after assisting an investigation in China. Shares and bonds related to CEFC China Energy plunged on the news, which was first reported by Chinese magazine Caixin. Chinese financial regulators in 2020 took over brokerages, trust companies and insurers linked to the group. Reporting by Brenda Goh and Xie Yu; Editing by Sumeet Chatterjee and Sonali PaulOur Standards: The Thomson Reuters Trust Principles.
Feb 17 (Reuters) - Chinese dealmaker Bao Fan, founder of investment bank China Renaissance Holdings Ltd (1911.HK), has gone missing in the latest disappearance of a top business executive, unnerving investors and sending its stock down as much as 50% on Friday. A China Renaissance spokesperson referred Reuters request for comment on Friday to the investment bank's public filing. The firm earned $20.6 million in Chinese related investment banking fees in 2022, down from $43.13 million a year earlier, the data showed. Bao started China Renaissance in 2005 as a two-person team, seeking to match capital-hungry startups with venture capitalist and private equity investors. China Renaissance is also an active investor in the tech sector.
China Renaissance CEO Bao Fan goes missing
  + stars: | 2023-02-17 | by ( Michelle Toh | ) edition.cnn.com   time to read: +3 min
Hong Kong CNN —One of China’s top investment bankers has become unreachable, according to his company. China Renaissance, an investment bank and private equity firm based in Beijing, said in a Thursday filing to the Hong Kong stock exchange that it “has been unable to contact” Bao Fan, its chairman and CEO. Shares of the company plunged as much as 50% in Hong Kong on Friday following the news. Bao did not immediately respond to messages from CNN on WeChat on Friday, while China Renaissance hasn’t yet responded to a request for comment. Chinese authorities detained Cong Lin, the company’s president, in September, it reported, citing unidentified sources.
Western Covid Medicine to China’s Rescue
  + stars: | 2022-12-28 | by ( The Editorial Board | ) www.wsj.com   time to read: 1 min
One conceit of Chinese leader Xi Jinping is that the West is in terminal decline and the Communist Party is destined to dominate the world in technology and politics. So don’t expect the Party media to celebrate the country’s emergency acceptance of Western Covid medicine. Shanghai Fosun Pharmaceutical Co. said Tuesday that Chinese users of its health app can now sign up to get doses of the Western-made BioNTech mRNA vaccine in Hong Kong. That’s happy news for affluent Chinese passport holders who can hop a flight to Hong Kong or nearby Macau, where vaccine tourism has been booming since Mainland infections began to rise.
[1/2] The BioNTech logo is seen at the booth of Fosun Pharmaceutical (Group) at the 2021 China International Fair for Trade in Services (CIFTIS) in Beijing, China September 3, 2021. REUTERS/Florence LoHONG KONG, Dec 27 (Reuters) - China's Shanghai Fosun Pharmaceutical Group (600196.SS) said users of its mobile health app in China can now register to take COVID-19 booster shots in Hong Kong using BioNTech's (22UAy.DE) vaccine. BioNTech and its partner for China - Fosun - were granted approval for their COVID-19 vaccine that is adapted for the BA.4 and the BA.5 subvariants of Omicron for people aged 12 and older in Hong Kong, the German company said on Dec. 23. The vaccine is the first and currently only variant-adapted vaccine available as a booster dose for individuals 12 years and older that has been granted approval in Hong Kong, BioNTech said at the time. A shipment of BioNTech COVID-19 vaccines meant for German nationals in China arrived at the German embassy in Beijing last week as cases in China soared after policymakers dropped nearly all of previous epidemic control protocols.
BioNTech ships COVID shots to China for use by Germans
  + stars: | 2022-12-22 | by ( ) www.reuters.com   time to read: +3 min
BioNTech said it is working with Shanghai Fosun Pharmaceutical (600196.SS) to deliver the shots to greater China, with availability expected in Beijing, Shanghai, Guangzhou, Shenyang and Chengdu. China would need to approve expanding access beyond the about 20,000 German nationals, the source said on Wednesday. "Most of Chinese here got the BioNTech vaccine, the vaccine that was first available. SinoVac vaccine was not available in Europe," a first-generation Chinese expatriate who has lived in Europe for more than a decade told Reuters. The expatriate, who asked to remain anonymous to protect their family in China, said that the government there might only make BioNTech shots available to Chinese nationals if it came to the worst-case scenario.
"I can confirm a shipment of the BioNTech vaccine is on its way to China," the person told journalists in Berlin. In return, Chinese citizens in Europe can be vaccinated with China's SinoVac (SVA.O), the spokesperson said. Experts predict that the country of 1.4 billion people could face more than a million COVID deaths next year. China is stuck between rising Covid-19 cases and stalled vaccination ratesNO WESTERN SHOTSChina has nine domestically developed COVID vaccines approved for use, more than any other country. While the shots became available in Hong Kong, Macau and Taiwan, the regulatory review for mainland China has not been concluded.
SHANGHAI, Dec 15 (Reuters) - Chinese luxury fashion conglomerate Lanvin Group, owner of the eponymous French fashion brand, said it is scouting for buys and will open new stores, after a New York SPAC listing on Thursday that raised $150 million and valued it at $1.31 billion. U.S.-listed shares of Lanvin opened about 4% higher at $10.25, and more than doubled to $20.25 in early trade. However, we still feel quite happy about what we have achieved in such a challenging environment," Lanvin Group Chairman and Chief Executive Joann Cheng told Reuters in an interview. Group revenue for the company, which was originally known as Fosun Fashion Group before it rebranded as Lanvin Group in October last year, grew 73% year-on-year to 202 million euros ($215 million) in the first half of 2022. Lanvin Group's listing will test investor appetite in less-established luxury groups.
A worker managed the inventory at a Lanvin store in Moscow in the early days of the Covid pandemic. Chinese-owned luxury fashion company Lanvin Group made its debut on the New York Stock Exchange on Thursday, after merging with a blank-check firm backed by Chinese private-equity firm Primavera Capital. Lanvin Group , which owns multiple Western brands, is controlled by China’s Fosun International Ltd. and has raised over $150 million in fresh capital at a valuation of $1 billion. It came to the market despite a sharp turn in fortunes for special-purpose acquisition companies and a wider slowdown in the market for new listings.
The report noted that potential disposals of non-core assets may include Fosun's stake in Cainiao. According to Refinitiv data, Fosun has agreed to sell or sold over $5 billion in assets this year. Reuters reported on Tuesday that Fosun has appointed Deutsche Bank to sell its stake in reinsurance company Peak Re. read moreIn 2013, Fosun had invested 500 million yuan as a co-founder of Cainiao, the logistics firm that underpins delivery for Alibaba's e-commerce marketplaces. Cainiao raked in 26 billion yuan in revenue in the six months ended September, up 19% year-on-year and accounting for 6% of Alibaba's total revenue.
Nov 7 (Reuters) - China's Fosun International Ltd (0656.HK) said on Monday it would raise $561 million by selling part of its shares in Zhaojin Mining Industry Co (1818.HK) as part of its ongoing string of asset sell-downs. The company, through one of its units, is offloading 654.1 million Zhaojin Mining shares for HK$6.72 each, a 1.8% discount from the closing price on Nov. 4. Fosun had owned about 22.85% of Zhaojin Mining's shares and will retain a 2.85% stake in the Hong Kong listed company. The transaction announced on Monday is the second time Fosun has sold Zhaojin stock and has raised $663.73 million from both deals. Fosun, controlled by billionaire entrepreneur Guo Guangchang, was once one of China's most aggressive dealmakers overseas, buying high-profile assets including resort brand Club Med.
BEIJING/HONG KONG, Oct 25 (Reuters) - Global credit rating agency Moody's downgraded Fosun International Ltd (0656.HK) by one notch on Tuesday and revised its outlook to "negative" from "ratings under review" amid concerns over the firm's accelerated asset sales. Fosun and its units had earlier cut stakes in firms such as New China Life Insurance (601336.SS) and Shanghai Yuyuan Tourist Mart Group (600655.SS). Fosun, controlled by billionaire entrepreneur Guo Guangchang, was once one of China's most aggressive dealmakers overseas, buying high-profile assets including resort brand Club Med. Fosun's cash on hand at the holding company level is insufficient to cover its short-term debt maturing over the next 12 months, Moody's added. Fosun also expects to gradually repay the outstanding senior notes and increase borrowings from banks, the report said.
BEIJING/HONG KONG, Oct 25 (Reuters) - Global rating agency Moody's downgraded Fosun International Limited (0656.HK) by one notch on Tuesday and revised its outlook to 'negative' from 'ratings under review', after the firm divested more assets to ease liquidity and debt burdens. "Moody's expects Fosun to face difficulties in refinancing its sizable short-term debt in public bond markets, both onshore and offshore, given the current weak market sentiment," the rating agency said. Fosun's cash on hand at the holding company level is insufficient to cover its short-term debt maturing over the next 12 months, Moody's said. Fosun's management also plans to gradually repay the outstanding senior notes and increase borrowings from banks, the report said. The company did not make any comments on the Bloomberg story or the Citigroup report in response to queries from Reuters.
PfizerКомпания Pfizer заявила, что её вакцина принесла $3,5 млрд выручки за первые три месяца 2021 года. Johnson & Johnson и AstraZenecaАмериканская компания Johnson & Johnson и англо-шведская AstraZeneca пообещали продавать свои вакцины на некоммерческой основе во время пандемии. Вакцина AstraZeneca от COVID-19 принесла создателям в первом квартале 2021 года $275 млн выручки. Johnson & Johnson сообщила, что её вакцина за первые три месяца года принесла $100 млн выручки. Kelly Scientific указывает сумму $59 млрд в 2021 году и снижение её до $47 млрд к 2026 году.
Persons: — BioNTech, Pfizer BioNTech, Johnson, Johnson AstraZeneca Johnson, Sinovac, Morningstar, Kelly, , Альберт Бурла, Алекс Горски, Джошуа Коэн, Джон ЛаМатинна, Карен Андерсен Organizations: Pfizer, BioNTech, Pfizer Fosun Pharma, Pfizer Pfizer, Johnson, AstraZeneca, AstraZeneca COVID, Guardian, Moderna Johnson, Forbes . Forbes, — Pfizer, Спутник, Всемирная организация здравоохранения (ВОЗ), Африканский союз, Альпари, & Locations: vc.ru, COVID, BioNTech Moderna, вакцинахЕС, США, Евросоюз, Бразилия, Чили, Сингапур, Малайзией, Филиппинами, Турция, Индонезия, Китай, Венгрия, Словакия, ЕС, Россия
В Мумбаи, крупнейшем городе Индии, на три дня приостановили прививки от коронавируса из-за нехватки вакцин. В Индии — резкий всплеск заболеваемости, каждый день выявляют сотни тысяч новых инфицированных, число смертей обновляет рекорды. Для сравнения: впервые этой цифры в статистике с начала эпидемии Индия достигла за шесть месяцев — в три раза более долгий срок. 12 апреля Индия одобрила экстренное применение российской вакцины «Спутник V», она стала третьей разрешенной в стране вакциной. Первую партию «Спутника V» Индия получит 1 мая.
Organizations: Reuters, Pharma, человекС, Российский фонд прямых инвестиций, Спутник Locations: Мумбаи, Индия, Россия, США
Total: 25